ALNY vs MIR · P/E 76, rev $1.29B vs P/E 170, rev $524.4M
Alnylam Pharmaceuticals Inc (ALNY) versus Mirion Technologies Inc (MIR) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Mirion Technologies Inc (MIR) is a specialty industrial machinery company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported MIR revenue for 2026-06-30 was $524.4M. Net income was $4.3M. MIR currently screens at market cap $4.17B and trailing P/E 170.4.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. MIR currently screens at market cap $4.17B and trailing P/E 170.4.
Not investment advice. Open the ALNY and MIR stock pages for the full models.
Not investment advice.